Alpha Financial Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$228K Buy
631
+44
+7% +$15.1K 0.12% 108
2026
Q1
$206K Sell
587
-98
-14% -$34.9K 0.12% 100
2025
Q4
$224K Buy
+685
New +$217K 0.14% 90
2025
Q2
Sell
-677
Closed -$211K 90
2025
Q1
$211K Sell
677
-119
-15% -$35.1K 0.17% 83
2024
Q4
$207K Buy
+796
New +$236K 0.16% 80
2024
Q3
Sell
-781
Closed -$244K 111
2024
Q2
$244K Buy
+781
New +$229K 0.21% 61
2024
Q1
Sell
-892
Closed -$257K 75
2023
Q4
$257K Sell
892
-278
-24% -$75.7K 0.25% 58
2023
Q3
$314K Buy
1,170
+25
+2% +$6.24K 0.37% 47
2023
Q2
$254K Buy
1,145
+141
+14% +$32.7K 0.27% 76
2023
Q1
$243K Buy
+1,004
New +$246K 0.27% 80

Other funds holding AMGN

Alpha Financial Partners's AMGN Position: Q2 2026 in Review

Alpha Financial Partners increased its Amgen (AMGN) stake by 7.5% in Q2 2026, buying an estimated $15.1K and bringing the position to 631 shares worth $228K. The position accounts for 0.12% of the portfolio, ranked #108.

Alpha Financial Partners first reported a position in AMGN in Q1 2023 and has held it in 10 quarters since. The position peaked at $314K in Q3 2023. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Alpha Financial Partners held 631 shares of Amgen worth $228K as of Q2 2026.
  • Alpha Financial Partners bought 44 Amgen shares in Q2 2026, an estimated $15.1K.
  • Amgen made up 0.12% of Alpha Financial Partners's portfolio in Q2 2026, its #108 holding.
  • Alpha Financial Partners first reported a position in Amgen in Q1 2023 and has held it in 10 quarters since.
  • Alpha Financial Partners's Amgen position peaked at $314K in Q3 2023.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Alpha Financial Partners's 13F filing for Q2 2026, filed 11 Aug 2026.